JPRN-jRCT1031180384进行中（未招募）未知
Evaluation of the effect of Saireito on postoperative swelling after total hip arthroplasty: A Randomized Controlled Trial - Effect of Saireito on postoperative swelling after THA
ozawa Masahiko0 个研究点目标入组 370 人开始时间: 2019年3月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 370
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patient with Osteoarthritis of Hip
- •Patient over 20 years old
- •Written informed consent
排除标准
- •Past history of Symptomatic Venous Thrombosis
- •Rheumatoid Arthritis
- •Current use of Steroids
- •Patient requiring perioperative Heparin bridging
- •Current use of Anticoagulant, Antiplatelet drug
- •Patient unable to use Enoxaparin
- •Underlying illness which causes Venous Thrombosis or edema
- •Severe hepatorenal dysfunction
- •Current use of Kampo medicine
- •Patient decided inappropriate to be an examinee
研究者
相似试验
已完成
不适用
Study on the clinical significance of Saireito in patients with hypertensive nephropathyhypertensive nephropathyJPRN-UMIN000011825ational Center for Global Health and Medicine20
已完成
2 期
Clinical study of the effectiveness of Saireito on the postoperative edema after blepharoptosis surgeryblepharoptosisJPRN-UMIN000016258Kansai Medical University30
进行中（未招募）
不适用
Objective evaluation of the effects of pasireotide on gastrointestinal and colorectal transit times, rectal wall properties, and postprandial response in patients with carcinoid diarrheaPatients with neuroendocrine tumors and carcinoid diarrheaMedDRA version: 15.1Level: LLTClassification code 10062476Term: Neuroendocrine tumorSystem Organ Class: 100000004864EUCTR2012-003939-27-DKKlaus Krogh
进行中（未招募）
1 期
europhysiological assessment of the effect of Sativex to treat spasticity following strokeEUCTR2016-001034-10-ITIRCCS-A.O.U. SAN MARTINO-IST41
尚未招募
不适用
The preventive effect of Ninjin'yoeito on sarcopenia among patients with advanced urotherial carcinoma who received systemic chemotherapy (A single-center, single-arm, open-label trial)Advanced urothelial carcinomaJPRN-UMIN000044092Hirosaki University hospital30